CIK 0001430306 · Non-accelerated filer<br>Smaller reporting company
Tonix Pharmaceuticals Holding Corp.
Sign in to watch- Ticker
- TNXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 261434750
- Phone
- 212-980-9155
- Business address
- 200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
- Former names
- TAMANDARE EXPLORATIONS INC.
- Open-market buys, last 90 days
- $60,455
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$60,455. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-06-25 | MARIO ERNEST Director | Purchase | +16,500 | $4.48 | $74K | 50,000 |
| 2018-06-14 | SULLIVAN GREGORY M Chief Medical Officer | Purchase | +10,000 | $3.97 | $40K | 20,482 |
| 2018-06-14 | SAENGER BRADLEY Chief Financial Officer | Purchase | +300 | $4.10 | $1K | 3,079 |
| 2018-06-14 | MORRIS JESSICA EDGAR Chief Operating Officer | Purchase | +300 | $4.19 | $1K | 1,638 |
| 2018-06-12 | LEDERMAN SETH Chief Executive Officer | Purchase | +1,000 | $4.37 | $4K | 16,166 |
| 2018-06-12 | LEDERMAN SETH Chief Executive Officer | Purchase | +2,000 | $4.37 | $9K | 20,463 |
| 2018-06-12 | GRACE PATRICK P Director | Grant or award · Stock Option | +20,000 | 20,000 | ||
| 2018-06-12 | GRANGE DAVID L Director | Grant or award · Stock Option | +20,000 | 20,000 | ||
| 2018-06-12 | LANDRY DONALD W Director | Grant or award · Stock Option | +20,000 | 20,000 | ||
| 2018-06-12 | MARIO ERNEST Director | Grant or award · Stock Option | +20,000 | 20,000 | ||
| 2018-06-12 | MATHER CHARLES E IV Director | Grant or award · Stock Option | +20,000 | 20,000 | ||
| 2018-06-12 | Rhodes John B Director | Grant or award · Stock Option | +30,000 | 30,000 | ||
| 2018-06-12 | Bell Margaret Smith Director | Grant or award · Stock Option | +20,000 | 20,000 | ||
| 2018-06-12 | Saks Samuel R Director | Grant or award · Stock Option | +20,000 | 20,000 | ||
| 2018-06-01 | Rhodes John B Director | Purchase | +7,500 | $3.33 | $25K | 23,470 |
| 2018-05-25 | LEDERMAN SETH Chief Executive Officer | Purchase | +4,000 | $3.17 | $13K | 26,700 |
| 2018-02-27 | MATHER CHARLES E IV Director | Option exercise | +750 | 12,580 | ||
| 2018-02-13 | SULLIVAN GREGORY M Chief Medical Officer | Grant or award · Stock Option | +58,726 | 58,726 | ||
| 2018-02-13 | SULLIVAN GREGORY M Chief Medical Officer | Grant or award · Stock Option | +58,725 | 58,725 | ||
| 2018-02-13 | LEDERMAN SETH Chief Executive Officer | Grant or award · Stock Option | +156,601 | 156,601 |
Page 11 of 25 · 482 trades